Exome sequencing in the assessment of congenital malformations in the fetus and neonate
Research output: Contribution to journal › Review article › peer-review
Authors
Colleges, School and Institutes
External organisations
- Birmingham Women's and Children's NHS Foundation Trust
- Fetal Medicine Centre, Birmingham Women's NHS Foundation Trust, Birmingham, UK.
Abstract
Major congenital anomalies are often associated with perinatal mortality, long-term morbidity and prolonged hospitalisation. Prenatal ultrasound remains the principle diagnostic test for many anomalies, but despite this up to one-third are only identified in the neonatal period. The primary step in determining underlying aetiology is to define accurately the phenotype by recognition of dysmorphology (both prenatally and postnatally). The potential introduction of next-generation sequencing, primarily through exome sequencing, into perinatal practice may improve the pathological diagnostic yield. However, clinicians must understand both the benefit and potential harms of this technology in facilitating the discovery of relevant pathogenic variants in the diagnosis and management of congenital malformations.
Details
| Original language | English |
|---|---|
| Pages (from-to) | F452-F456 |
| Number of pages | 5 |
| Journal | Archives of disease in childhood. Fetal and neonatal edition |
| Volume | 104 |
| Early online date | 1 Feb 2019 |
| Publication status | Published - 1 Jul 2019 |
Keywords
- PAGE study, exome sequencing, monogenic disorders, next generation sequencing, perinatal